 HAYWARD, Calif., Sept. 8, 2021 PRNewswire -- Benitec Biopharma Inc. NASDAQ: BNTC, a development-stage biotechnology company focused on the advancement of novel genetic medicines, today provided an overview of the key elements of the BB-301 Phase 1b2a clinical trial design. 